Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan for post-endoscopic variceal ligation ulcer
PACTR202207793488326Phase 2Not yet recruiting
- Sponsor
- General Authority for Teaching Hospitals and Institutes
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of vonoprazan in esophageal varices (3 arms), sponsored by General Authority for Teaching Hospitals and Institutes. Primary endpoints: Post-endoscopic variceal ligation ulcer presence, Number of post-ligation ulcers and 2 more. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
vonoprazan
03
Conditions
esophageal varices
Beyond the preview
Go deeper on PACTR202207793488326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202207793488326.